Foghorn Therapeutics Inc.

This week, we’re joining the scientific community for a special conference from the American Association for Cancer Research on expanding and translating cancer synthetic vulnerabilities. See the program and be sure to catch our presentations: https://bit.ly/45f6CAR #drugdevelopment #oncology

We had a great time at #ASCO24 connecting with scientists and researchers to discuss the latest #innovation in #cancerresearch. See everyone next year! #oncology

Our Chief Scientific Officer, Steven Bellon, PhD, highlighted his key takeaways from the Future of Disease and Chromatin Regulation Summit that Foghorn recently hosted. Read his article to learn more about the scientific knowledge around chromatin biology and why it’s pivotal to be exposed to diverse perspectives in this highly exciting, challenging area of science. #biotechnology #science #innovation #drugdiscovery

Today we recognize #WorldBloodCancerDay. Learn how you can contribute to the battle against #bloodcancers, including rare forms like acute myeloid #leukemia (#AML). https://bit.ly/3ybQtxG #WBCD

Catch up with Foghorn at two investor conferences in June. Our leadership team will be participating in the Jefferies Global Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference. Find more details here: https://bit.ly/4ay77Hn

Today, we announced the closing of our previously announced registered direct offering, with gross proceeds of the offering totaling approximately $110 million. Learn more here: https://lnkd.in/eyiU8ybr #financing #biotech

At Foghorn, collaboration fuels our innovation as we strive to transform patients' lives. Hear Jared Subiono’s perspective on our team and the work we do. Check out our #culture page to learn more and explore available positions to join our mission today! https://bit.ly/48vd0Up #LifeAtFoghorn #STEMCareers #biotechnology #nowhiring

This morning, we announced the pricing of a registered direct offering of common stock. Read more here: https://bit.ly/3QUkpqx

Each May we recognize National Cancer Research Month. Thanks to our scientists & researchers who are addressing breakdowns within the chromatin regulatory system – which is associated with over 50% of all #cancers. Learn about our approach: https://lnkd.in/erB6H8-c #NCRM24

We recently hosted our first Future of Disease and Chromatin Regulation Summit.   It was great to hear perspectives from world-renowned key opinion leaders in gene regulation, chromatin biology, and epigenetics about the current and future direction of therapeutic opportunities in chromatin-related biology. Thank you to everyone who joined us, and a special thanks to our hosts and speakers, William Sellers, Scott Armstrong MD, PhD, Jeffrey Settleman, Ernst Dow, Catriona Jamieson, Johnna Wesley, Frank Dorsey, Ho Man Chan, Adrian Gottschalk, Steven Bellon, PhD, Cigall Kadoch, Danette Daniels, Janice Lee, Gromoslaw (Gromek) Smolen, and Karin Hellsvik!    #biotechnology #science #innovation #drugdiscovery